Introduction

Migraines are a neurological disorder characterized by recurrent, often debilitating headaches that can interfere with daily life. Chronic migraine, defined as experiencing headaches on 15 or more days per month for at least three months, affects an estimated 1–2% of the global population. Among Black women ages 20–30, migraines represent a significant but underrecognized health issue. This population faces unique challenges related to diagnosis, treatment, and health disparities, which can worsen the burden of disease.

Prevalence and Risk Factors

While migraines affect women disproportionately compared to men, Black women are less likely to receive a formal diagnosis. Research suggests that genetic predisposition may play a role, as family history of migraines is common. Hormonal changes, particularly during reproductive years, contribute to higher migraine rates in young women. Socioeconomic and healthcare barriers often delay diagnosis and access to effective therapies. Stress and systemic inequities, including racism and discrimination, may exacerbate migraine frequency and severity.

Clinical Features

Black women with chronic migraines typically experience:

• Severe throbbing or pulsating pain, often on one side of the head

• Sensitivity to light, sound, or smells

• Nausea and vomiting

• Aura symptoms in some cases, such as visual disturbances or tingling sensations

However, cultural perceptions of pain and underreporting may contribute to misdiagnosis or the assumption that symptoms are related to tension headaches or sinus issues.

Barriers to Care

Several factors make chronic migraine particularly challenging for Black women ages 20–30. Underdiagnosis, studies show that Black patients are less likely to receive a migraine diagnosis despite presenting with classic symptoms. Limited access to specialists, neurologists and headache specialists are less accessible in underserved communities. Medication disparities, prescriptions for triptans and newer migraine therapies are less frequently given to Black women compared to white counterparts. Cultural stigma, myths surrounding migraines as “just bad headaches” can discourage seeking medical care.

Management Strategies

Effective management requires both medical and lifestyle interventions:

• Pharmacological treatments: Preventive therapies (beta-blockers, antiepileptics, CGRP inhibitors) and acute medications (NSAIDs, triptans).

• Lifestyle modifications: Adequate sleep, hydration, stress reduction, and avoidance of known triggers (such as caffeine or skipped meals).

• Holistic care: Incorporating mental health support and addressing social determinants of health is critical.

• Patient advocacy: Increasing awareness and promoting culturally competent care can help reduce disparities.

Conclusion

Chronic migraines in Black women ages 20–30 remain underdiagnosed and undertreated, leading to unnecessary suffering during formative years of career, education, and family development. Addressing diagnostic bias, expanding access to neurologic care, and tailoring treatment approaches to the unique needs of this group are essential steps toward health equity.